Composition
- Active ingredients
- LETROZOLE 200MG; RIBOCICLIB SUCCINATE 2.5MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA215975.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Letrozole;Vribociclib Succinate
- Active substance
- letrozole
- Drug class
- Aromatase inhibitors
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- MSN Labs PVT LTD
- Status
- Tentative approval
- FDA approval
- 1 May 2023
- Application
- ANDA215975-001